Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $191.2, denoting a +2.2% move from the preceding trading day.
Tenet Healthcare is expanding its outpatient footprint through USPI, with strong first-quarter results and new ASC investments fueling long-term growth.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In the most recent trading session, Tenet Healthcare (THC) closed at $180.88, indicating a +1.19% shift from the previous trading day.
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare (THC) closed the most recent trading day at $179.11, moving +2.55% from the previous trading session.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet (THC) possesses solid growth attributes, which could help it handily outperform the market.